Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease - Boza-Serrano, Antonio; Vrillon, Agathe; Minta, Karolina; Paulus, Agnes; Camprubí-Ferrer, Lluís; Garcia, Megg; Andreasson, Ulf; Antonell, Anna; Wennström, Malin; Gouras, Gunnar; Dumurgier, Julien; Cognat, Emmanuel; et al. (Acta neuropathologica, 2022)
Keywords: Age; Alzheimer Disease - pathology; Alzheimer's disease; Amyloid beta-Peptides - metabolism; Animal models; Animals; Basic Medicine; beta-Galactosidase - metabolism; Biomarkers; Biomarkers - cerebrospinal fluid; Brain - pathology; Central nervous system; Cerebrospinal fluid; Chitinase-3-Like Protein 1 - metabolism; Galectin 3; GAP-43 protein; GAP-43 Protein - metabolism; Glial fibrillary acidic protein; Hippocampus; Humans; Immunohistochemistry; Inflammation; Medical and Health Sciences; Medicin och hälsovetenskap; Medicine; Medicine & Public Health; Medicinska och farmaceutiska grundvetenskaper; Mice; microglia; Microglial cells; Neurodegeneration; Neurodegenerative diseases; Neurogranin; Neurosciences; Neurosciences & Neurology; Neurovetenskaper; Original Paper; Pathology; pathway; Plaque, Amyloid - pathology; Principal components analysis; receptor; Senile plaques; strem2; Tau protein; tau Proteins - metabolism; β-Amyloid; β-Galactosidase